Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 1/20 | 0.73 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.73 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.73 |
| ▸ | CCR2 | P41597 | 3/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CRHBP | P24387 | 1/20 | 0.54 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11027219 | 0.88 | ERBB2 (0.71) | ERBB2HSP90AA1HSP90AB1CCR2PGR | |
| SCHEMBL5801599 | 0.88 | ERBB2 (0.67) | ERBB2HSP90AA1HSP90AB1CCR2PGR | |
| SCHEMBL12838827 | 0.85 | ERBB2 (1.00) | ERBB2HSP90AA1HSP90AB1CCR2ALDH1A1 | |
| SCHEMBL2766570 | 0.85 | ERBB2 (0.68) | ERBB2HSP90AA1HSP90AB1CCR2PGR | |
| SCHEMBL1138730 | 0.85 | ERBB2 (0.68) | ERBB2HSP90AA1HSP90AB1CCR2PGR | |
| SCHEMBL10891615 | 0.85 | ALDH1A1 (0.67) | ERBB2HSP90AA1HSP90AB1CCR2ALDH1A1 | |
| SCHEMBL6802646 | 0.85 | ERBB2 (0.77) | ERBB2HSP90AA1HSP90AB1CCR2ALDH1A1 | |
| SCHEMBL12032535 | 0.83 | ERBB2 (0.66) | ERBB2HSP90AA1HSP90AB1CCR2PGR | |
| SCHEMBL5956021 | 0.83 | APP (0.66) | CCR2ALDH1A1LMNAHTT | |
| SCHEMBL9931082 | 0.83 | CCR2 (0.67) | CCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ERBB2 221/4885HSP90AA1 4759/4885HSP90AB1 4609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.